跳至主要内容
临床试验/JPRN-jRCTs052220071
JPRN-jRCTs052220071招募中3 期

Phase III study of waterjet versus ultrasonic device in transection efficacy during anatomical liver resection - WAUTEAR trial

eno Masaki0 个研究点目标入组 250 人开始时间: 2022年8月9日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • (1) Age 20 years or older.
  • (2) ECOG Performance Status 0 to 2.
  • (3) Written consent provided.
  • (4) Scheduled to undergo (open/laparoscopic) liver resection due to liver disease, or to undergo liver resection as a donor for living-donor liver transplantation.
  • (5) Scheduled to undergo the following surgical procedures: right lobectomy, left lobectomy, right posterior sectionectomy, segment VII segmentectomy (for patients with liver disease) and right lobectomy, left lobectomy (for donors)

排除标准

  • (1) Venous tumor thrombus (Vv2, 3).
  • (2) Biliary tumor thrombus (B3, 4).
  • (3) Needing biliary or vascular reconstruction.
  • (4) Dissection area overlaps with area of previous partial hepatectomy.
  • (5) Difficulty in taping hepatoduodenal ligament.
  • (6) Requiring resection of other organs except for gallbladder.
  • (7) BMI of 30 or more.
  • (8) Child-Pugh grade B or C.
  • (9) Platelet count <=10x104/micro-L.
  • (10) NYHA grade III or more.
  • (11) Implanted cardiac pacemaker or cardioverter defibrillator.
  • (12) Severe renal dysfunction (serum Cr >1.5 mg/dL).
  • (13) Severe respiratory dysfunction (forced expiratory volume in 1 second <1L or requiring rest because of shortness of breath during 100m or several minutes' walking).
  • (14) Other non-appropriate conditions, as determined by the principal investigator.

研究者

发起方
eno Masaki

相似试验

WAUTEAR trial | 临床试验